Phase 3 PROPEL 3 data published today in NEJM were simultaneously presented at ICCBH in a late-breaking oral presentation; presentation includes new arm span Z-score data showing a statistically ...
Extreme fear has returned as investors rotate away from momentum stocks and toward high-quality companies. Click here to know ...